David Sunseri, Ph.D, became CEO of PMI BioPharma Solutions in August 2018, advancing from his role as senior vice president of pharmaceutical development and chief business development officer. As CEO, David applies his experience with leading development programs and developing new business opportunities to craft the overall strategy that is driving growth for PMI Bio.
Prior to PMI Bio, David spent almost four years at Berg, LLC, in positions of increasing responsibility, leading all aspects of chemistry, manufacturing, and controls (CMC). Most recently, as vice president of product development, he oversaw clinical trial manufacturing, engineering operations, supply chain, and formulations. He also spent 10 years with Schering-Plough and Merck in small molecule inhalation and parenteral development, and in commercial manufacturing of inhalation and medical device products.
David received a bachelor’s degree in chemistry from the University of North Alabama and a Ph.D. in analytical chemistry, specializing in chromatography, from Florida State University under the direction of John G. Dorsey.
He serves as treasurer for the Foundation Board of Directors, chair of the budget, finance, and audit committee, and member of the executive committee, all at the University of North Alabama. David is also a member of the University of North Alabama’s College of Arts and Sciences advisory council.